research often focused on this disease. As palliative services become more available to persons dying of other chronic conditions, the methods presented herein can be expanded to non-cancer end-of-life care.
To identify inadequacies in palliative care provision, population-based retrospective studies can be carried out across Canada by learning from progress being made in Nova Scotia (NS). Concurrently, population-based methods must be developed to prospectively identify persons with palliative care needs and to enable intervention studies.
NS research provides a model for equity studies reporting demographic and service variations in palliative program registration 12 and provision of palliative radiation. 13 Physician and hospital service utilization is now being investigated. 14, 15 Studies of narcotic analgesic use 16 and nursing workload measures 17 are planned. For these retrospective studies, the study subjects are all persons dying of cancer. The subjects were identified from the Nova Scotia Cancer Registry that contains provincial Vital Statistics (VS) death registrations. The subjects are an unbiased set of persons likely to have end-of-life needs. The validity of the VS cause of death can be ascertained by comparison to diagnoses recorded in the disease registry.
Canadian provincial/territorial Cancer Registries (CR) identify all persons diagnosed with cancer since 1969 18 from pathology reports, hospital separations and cancer centre visits using International Classification of Disease -Oncology (ICD-O) codes. Vital Statistics (VS) death registrations have ICD-9 cause of death codes. The ICD-9 VS and ICD-O CR codes can be grouped into 10 common categories (Table I) .
For NS studies, if a primary cancer site at diagnosis is also recorded as a cause of death, it is assumed that the person would probably require supportive cancer care at the end of life. The extent of agreement between CR and VS cancer sites was ascertained for NS by comparing underlying and other VS cancer causes of death to CR primary cancer(s) at diagnosis. At least one of the cancer causes of death was found as a primary cancer diagnosis for 90.5% of the people dying of cancer. Agreement for diagnoses microscopically confirmed was similar to those clinically diagnosed.
For the 9.5% in disagreement, anatomically adjacent and metastatic sites, as well as diagnostic uncertainty, were typically involved. The VS cause of death appears plausible given the primary cancer site. Grouped ICD-9 VS cancer cause of death appears to be a valid classification for retrospective study subjects.
Disease registry managers should lead in linking death records to administrative databases for retrospective assessment of palliative care provision. Province-wide, patient-specific profiles of service provision should be generated over time, compared to other geographic areas, and analyzed by sociodemographic determinants such as age, sex, cause of death, urban/rural place of residence, and location of death (hospital, home, nursing home). In all Canadian provinces/territories, hospital and physician services databases exist. In many, palliative radiation, pharmaceutical and home care data are accessible. A major effort is now needed to enable retrospective, endof-life studies across Canada.
Concurrently, prospective study methods must be developed for the comparison of outcomes from various models of palliative care provision and the evaluation of palliative care interventions. As Canadian cancer registries progress to include stage of disease at diagnosis, 19 consensus should be sought on which markers of disease progression should be added to identify persons likely to require palliative services.
New data collection for prospective studies must be feasible for palliative and home care programs, long term care facilities, and hospitals. Data should be meaningful for planning and policy setting by agencies providing data as well as chronic 
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disease program managers, drug programs, and clinicians.
In conclusion, the authors recommend that VS cause of death be used to classify persons in retrospective studies of equity in service provision at the end of life to persons dying of cancer across Canada. This method should be used for other chronic diseases such as AIDS, Lou Gerhig's and multiple sclerosis. Concurrently, classification and design issues for prospective studies should be addressed. 
